# Specifying and Treating Anxiety in Autism Research

> **NCT03279471** · PHASE2 · COMPLETED · sponsor: **University of California, Davis** · enrollment: 68 (actual)

## Conditions studied

- Autism Spectrum Disorder
- Anxiety

## Interventions

- **DRUG:** Sertraline
- **BEHAVIORAL:** CBT/BIACA
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03279471
- **Lead sponsor:** University of California, Davis
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-01
- **Primary completion:** 2023-02-22
- **Final completion:** 2023-02-22
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2023-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03279471

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03279471, "Specifying and Treating Anxiety in Autism Research". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03279471. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*